Analysis of TP53 gene mutations in human lung cancer:: Comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing

被引:21
作者
Holmila, R [1 ]
Husganel-Pursiainen, K [1 ]
机构
[1] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, FI-00250 Helsinki, Finland
来源
CANCER DETECTION AND PREVENTION | 2006年 / 30卷 / 01期
关键词
capillary electrophoresis; SSCP; DGGE; TP53; gene; mutation; human lung cancer; single strand conformation polymorphism; DNA extraction; direct sequencing; detection methods; sensitivity; sample preparation;
D O I
10.1016/j.cdp.2005.10.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Automated capillary electrophoresis single Strand conformation polymorphism (CE-SSCP), denaturant gradient gel electrophoresis (DGGE), and direct sequencing were compared to investigate the benefits and sensitivity of each of the methods for detection of unknown 7753 Mutations in human lung cancer. Methods: Twenty previously analyzed DNA samples from lung tumors were examined under dummy laboratory codes for occurrence Of mutations of the TP53 gene. Results: Mutations were found in 17 samples; 15 (88%) of them were detected by DGGE, 16 (94%) by CE-SSCP and 12 (71%) by direct sequencing. One of the two mutations that remained undetected in DGGE was in fact Outside the Sequence area covered by DGGE screening, thus rendering DGGE and CE-SSCP equally efficient in mutation detection. Direct sequencing performed less well in finding mutations than the two other assays, as also shown previously. Conclusion: The study showed that CE-SSCP is a fast and highly reproducible method, which is considerably less laborious compared to DGGE, for screening of unknown TP53 mutations. (c) 2005 International Society for Preventive Oncology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 19 条
  • [1] Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France)
    Breton, J
    Sichel, F
    Abbas, A
    Marnay, J
    Arsène, D
    Lechevrel, M
    [J]. MUTAGENESIS, 2003, 18 (03) : 299 - 306
  • [2] TP53: a key gene in human cancer
    Guimaraes, DP
    Hainaut, P
    [J]. BIOCHIMIE, 2002, 84 (01) : 83 - 93
  • [3] Guldberg P, 1997, HUM MUTAT, V9, P348, DOI 10.1002/(SICI)1098-1004(1997)9:4<348::AID-HUMU8>3.3.CO
  • [4] 2-7
  • [5] Hainaut P, 2000, ADV CANCER RES, V77, P81
  • [6] Holmila R, 2004, TOXICOL APPL PHARM, V197, P255
  • [7] Lung cancer and past occupational exposure to asbestos -: Role of p53 and K-ras mutations
    Husgafvel-Pursiainen, K
    Karjalainen, A
    Kannio, A
    Anttila, S
    Partanen, T
    Ojajärvi, A
    Vainio, H
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) : 667 - 674
  • [8] Hussain SP, 1998, CANCER RES, V58, P4023
  • [9] A streamlined mutation detection system: Multicolor post-PCR fluorescence labeling and single-strand conformational polymorphism analysis by capillary electrophoresis
    Inazuka, M
    Wenz, HM
    Sakabe, M
    Tahira, T
    Hayashi, K
    [J]. GENOME RESEARCH, 1997, 7 (11): : 1094 - 1103
  • [10] Larsen LA, 1999, HUM MUTAT, V13, P318, DOI 10.1002/(SICI)1098-1004(1999)13:4<318::AID-HUMU9>3.0.CO